Literature DB >> 18689382

Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial.

Ling Hao1, Quan-He Yang, Zhu Li, Lynn B Bailey, Jiang-Hui Zhu, Dale J Hu, Bo-Lan Zhang, J David Erickson, Le Zhang, Jacqueline Gindler, Song Li, Robert J Berry.   

Abstract

BACKGROUND: There are no large randomized trials of the effect of folic acid dosing regimens on blood folate and homocysteine concentrations.
OBJECTIVE: We aimed to evaluate the changes in folate and homocysteine concentrations in response to different folic acid doses and to withdrawal in young women not exposed to other sources of folic acid.
DESIGN: Women (n = 1108) were randomly assigned to 1 of 6 intervention groups for which daily intakes of folic acid for 6 mo were 100 microg 1 time/d, 25 microg 4 times/d, 400 microg 1 time/d, 100 microg 4 times/d, 4000 microg 1 time/d, or 4000 microg 1 time/wk. Plasma and red blood cell folate and homocysteine concentrations were measured at baseline; at 1, 3, and 6 mo; and 3 mo after the discontinuation of folic acid.
RESULTS: Folate and homocysteine concentrations were not different at baseline between the groups who had the same daily intake of folic acid as a single dose or multiple doses (P = 0.058). Plasma folate concentrations plateaued at 3 mo with 108% (95% CI: 97.7%, 120%), 259% (95% CI: 240%, 279%), 460% (95% CI: 417%, 503%), and 142% (95% CI: 123%, 162%) observed increases for the folic acid groups receiving 100, 400, and 4000 microg/d and 4000 microg/wk, respectively. The rate of reduction in folate concentrations during the 3 mo after cessation of folic acid was dose-dependent-higher intakes were associated with faster reductions.
CONCLUSIONS: Changes in folate and homocysteine concentrations were unaffected by different dosing schedules. After folic acid cessation, blood folate declined rapidly, which indicated that the intervention-enhanced folate status was rapidly diminished.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689382     DOI: 10.1093/ajcn/88.2.448

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  22 in total

1.  Transcobalamin 776C→G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake.

Authors:  Hathairat Sawaengsri; Peter R Bergethon; Wei Qiao Qiu; Tammy M Scott; Paul F Jacques; Jacob Selhub; Ligi Paul
Journal:  Am J Clin Nutr       Date:  2016-10-12       Impact factor: 7.045

Review 2.  Role of folic acid in nitric oxide bioavailability and vascular endothelial function.

Authors:  Anna E Stanhewicz; W Larry Kenney
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

Review 3.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

4.  Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects.

Authors:  Lisa A Houghton; Andrew R Gray; Meredith C Rose; Jody C Miller; Nicola A Hurthouse; Jesse F Gregory
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

5.  Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation.

Authors:  Meng-Yu Chen; Charles E Rose; Yan Ping Qi; Jennifer L Williams; Lorraine F Yeung; Robert J Berry; Ling Hao; Michael J Cannon; Krista S Crider
Journal:  Am J Clin Nutr       Date:  2019-05-01       Impact factor: 7.045

6.  Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: results from a crossover trial.

Authors:  Cheryl A M Anderson; Shirley A A Beresford; Dale McLerran; Johanna W Lampe; Samir Deeb; Ziding Feng; Arno G Motulsky
Journal:  Mol Nutr Food Res       Date:  2013-03-04       Impact factor: 5.914

7.  Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone.

Authors:  Herbert Wiesinger; Urte Eydeler; Frank Richard; Dietmar Trummer; Hartmut Blode; Beate Rohde; Konstanze Diefenbach
Journal:  Clin Drug Investig       Date:  2012-10-01       Impact factor: 2.859

8.  Dietary supplement use and smoking are important correlates of biomarkers of water-soluble vitamin status after adjusting for sociodemographic and lifestyle variables in a representative sample of U.S. adults.

Authors:  Christine M Pfeiffer; Maya R Sternberg; Rosemary L Schleicher; Michael E Rybak
Journal:  J Nutr       Date:  2013-04-10       Impact factor: 4.798

9.  The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies.

Authors:  Natalie J Colson; Helen L Naug; Elham Nikbakht; Ping Zhang; Joanna McCormack
Journal:  Eur J Nutr       Date:  2015-10-23       Impact factor: 5.614

10.  Review of Existing Models to Predict Reductions in Neural Tube Defects Due to Folic Acid Fortification and Model Results Using Data from Cameroon.

Authors:  Hanqi Luo; Kenneth H Brown; Christine P Stewart; Laurel A Beckett; Adrienne Clermont; Stephen A Vosti; Jules M Guintang Assiene; Reina Engle-Stone
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.